Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02260609
What this trial is testing

GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds

Who this might be right for
Complex Diabetic Foot Wounds
Osiris Therapeutics 31
Testing effectiveness (Phase 2)Ended earlyNCT00880009
What this trial is testing

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 16
Early research (Phase 1)Study completedNCT02182232
What this trial is testing

A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06852963
What this trial is testing

A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001

Who this might be right for
Retinitis Pigmentosa 11Retinal DegenerationRetinal Disease+2 more
PYC Therapeutics 17
Post-approval studies (Phase 4)WithdrawnNCT00702793
What this trial is testing

Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)

Who this might be right for
SchizophreniaSchizoaffectivePsychosis
University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT01366521
What this trial is testing

Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils

Who this might be right for
Asthma
GlaxoSmithKline 70
Early research (Phase 1)Study completedNCT01205321
What this trial is testing

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 19
Testing effectiveness (Phase 2)Ended earlyNCT00903006
What this trial is testing

Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT05518578
What this trial is testing

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Who this might be right for
EpilepsySeizures, Epileptic
Supernus Pharmaceuticals, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT03226678
What this trial is testing

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

Who this might be right for
Warm Autoimmune Hemolytic AnemiaCold Agglutinin Disease
Apellis Pharmaceuticals, Inc. 24
Post-approval studies (Phase 4)Study completedNCT03350815
What this trial is testing

Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Novartis Pharmaceuticals 322
Post-approval studies (Phase 4)Study completedNCT03521635
What this trial is testing

The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 98
Not applicableStudy completedNCT04796935
What this trial is testing

Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control

Who this might be right for
Central Nervous System InfectionsPseudotumor CerebriNeurological Disorder+4 more
IntuiTap Medical, Inc 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT04920708
What this trial is testing

Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

Who this might be right for
Metastatic Breast CancerER+ Breast CancerAdvanced Breast Cancer
Royal Marsden NHS Foundation Trust 57
Large-scale testing (Phase 3)Study completedNCT00648908
What this trial is testing

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 269
Testing effectiveness (Phase 2)Study completedNCT00815308
What this trial is testing

Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shandong Cancer Hospital and Institute 55
Early research (Phase 1)UnknownNCT03310008
What this trial is testing

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases

Who this might be right for
Colon Cancer Liver Metastasis
Celyad Oncology SA 36
Testing effectiveness (Phase 2)Ended earlyNCT04489940
What this trial is testing

Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
EMD Serono Research & Development Institute, Inc. 11
Not applicableStudy completedNCT01225250
What this trial is testing

Safety and Efficacy Study of Polydioxanone (PDS) Plates in Rhinoplasty

Who this might be right for
Rhinoplasty
DeNova Research 30
Early research (Phase 1)Looking for participantsNCT07044050
What this trial is testing

A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma With no Other Specification
Emercell SAS 10
Next Page